Comparison of composite disease activity indices for rheumatoid arthritis

References

• van der Heijde DM, van't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the devel-opment of a disease activity score. Ann Rheum Dis. 1990;49:916–20.
   Google Scholar
• van der Heijde DM, van't Hof MA, van Riel PL, van Leeuwen MA, van Rijswijk MH, van de Putte LB. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis. 1992;51:177–81.
   Google Scholar
• Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–8.
   Google Scholar
• van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996;39:34–40.
   Google Scholar
• Prevoo ML, van Gestel AM, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the dis-ease activity score. Br J Rheumatol. 1996;35:1101–5.
   Google Scholar
• Fransen J, Welsing PM, de Keijzer RM, van Riel PL. Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity (abstract). Ann Rheum Dis. 2004;62[Suppl 11:151.
   Google Scholar
• DAS Score NL: Disease Activity Score in rheumatoid arthritis. Available at: http://www.das-score.nl/www.das-score.nl/index.html. Accessed 15 July 2010.
   Google Scholar
• Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003;42:244–57.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Segurado OG. Assessment of disease activity and treatment response to adalimumab (HUMIRA) in RA with the Simplified Disease Activity Index (SDAD(abstract). Arthritis Rheum. 2004;50[Suppl 1]:S190–1.
   Google Scholar
• Soubrier M, Zerkak D, Dougados M. Should we revisit the def-inition of higher disease activity state in rheumatoid arthritis (RA) (abstract)? Arthritis Rheum. 2004;50[Suppl 9]:S386.
   Google Scholar
• Wong AL, Harker JO, Park GS, Paulus HE. Longitudinal mea-surement of RA disease activity in a clinical practice setting; usefulness of the SDAI(abstract). Arthritis Rheum. 2004;50 [Suppl 9]:S386–7.
   Google Scholar
• Leeb BF, Andel I, Sautner J, Bogdan M, Maktari A, Nothnagl T, Rintelen B. Disease activity measurement of rheumatoid arthritis: comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine. Arthritis Rheum. 2005;53: 56–60.
   Google Scholar
• Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005;7:R796–806.
   PubMed Web of Science ®Google Scholar
• NinJa: National Database of Rheumatic Disease by iR-net in Japan. Available at: http://www.ninja-ra.jp/C_TOP-E.html. Accessed 3 May 2010.
   Google Scholar
• Yamanaka H, Tohma S. Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice. Mod Rheumatol. 2006;16:75–6.
   PubMedGoogle Scholar
• Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining cri-teria for disease activity states. Arthritis Rheum. 2005;52:2625–36.
   PubMed Web of Science ®Google Scholar
• Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Com-parison of Disease Activity Score (DAS)28-erythrocyte sedi-mentation rate and DA528-C-reactive protein threshold values. Ann Rheum Dis. 2007;66: 407–9.
   Google Scholar
• Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measure. 1960;20:37–46.
   Web of Science ®Google Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.
   PubMed Web of Science ®Google Scholar
• Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Ser B (Methodol). 1964;26:211–52.
   Google Scholar
• Talstad I, Scheie P, Dalen H, Roli J. Influence of plasma proteins on erythrocyte morphology and sedimentation. Scand J Haema-tol. 1983;31:478–84.
   PubMedGoogle Scholar
• Kushner I. C-reactive protein in rheumatology. Arthritis Rheum. 1991;34:1065–8.
   PubMed Web of Science ®Google Scholar
• Gblfe A, Aletaha D, Saxne T, Geborek P. Disease activity level, remission and response in established rheumatoid arthritis: perfor-mance of various criteria sets in an observational cohort, treated with anti-TNF agents. BMC Musculoskelet Disord. 2009;10:41.
   PubMedGoogle Scholar
• Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, et al. Disease Activity Score 28 (DA528) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DA528 using erythrocyte sedi-mentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis. 2007;66:1221–6.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the man-agement of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010; 69:964–75.
   PubMed Web of Science ®Google Scholar